What is Mareana?
Mareana operates at the intersection of enterprise software, artificial intelligence, and critical business operations. Its AI-native platform is engineered for regulated environments, providing real-time insights essential for Manufacturing, Supply Chain, and Sustainability initiatives. The company's robust client roster includes three of the top ten pharmaceutical firms, leading global medical device manufacturers, and prominent consumer health product companies. Mareana's platform features an integrated Data Science Studio and No-Code ML environments, empowering users to rapidly develop AI/ML models, Digital Twins, and conduct advanced analytics to optimize business performance.
How much funding has Mareana raised?
Mareana has raised a total of $518K across 2 funding rounds:
Debt
$150K
Debt
$368K
Debt (2020): $150K with participation from PPP
Debt (2021): $368K led by PPP
What's next for Mareana?
The recent major strategic investment signifies a crucial phase of growth and expansion for Mareana. This capital infusion is expected to accelerate the development and deployment of its advanced AI solutions, further solidifying its market position within the highly regulated pharmaceutical and healthcare sectors. Mareana's focus on enabling swift adaptation to evolving dynamics positions it for continued success in driving operational efficiency and sustainable practices for its enterprise clientele.
See full Mareana company page
